INO: Inovio Pharmaceuticals Inc

INO新闻

• 21:05 12 Health Care Stocks Moving In Tuesday's After-Market Session
• 20:09 Inovio Wins $80,416,101 Judgment Against VGXI And GeneOne, Says Defendants’ Financial Condition Likely To Impair Collection
• 20:09 Inovio赢得针对VGXI和GeneOne的80,416,101美元判决，称被告的财务状况可能会影响执行回收
• 14:45 FDA Backs PFE's Tukysa Combo in Front-Line Maintenance Breast Cancer
• 14:44 PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know
• 15:08 PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?
• 14:17 Can PGEN's AdenoVerse Pipeline Create Growth Beyond Papzimeos?
• 14:12 Precigen Gains 43% in 3 Months: Is It an Indication to Buy the Stock?
• 15:03 Can Papzimeos Drive Precigen's Growth Through the Rest of 2026?
• 23:17 Inovio Pharmaceuticals, Inc. (INO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
• 07:01 Inovio Stock: The Final Countdown To A Binary FDA Decision (NASDAQ:INO)
• 01:02 Inovio Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:INO) 2026-08-12
• 12:50 Bet on 5 Top-Ranked Stocks With Rising P/E
• 13:55 Inovio: All Eyes On INO-3107 As Binary FDA Decision Looms (NASDAQ:INO)
• 01:30 Inovio Pharmaceuticals, Inc. (INO) Q1 2026 Earnings Call Transcript
• 22:22 Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call - Inovio Pharmaceuticals (NASDAQ:INO)
• 15:42 ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth
• 15:35 Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up
• 15:30 RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
• 16:00 RARE Q1 Loss Wider Than Expected, Sales Down Y/Y on Seasonal Effect
• 15:52 NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up
• 17:16 Viatris Gears Up to Report Q1 Earnings: What's in the Cards?
• 15:32 Catalyst Pharmaceutics to Report Q1 Earnings: Is a Beat in the Cards?
• 17:24 Pacira Q1 Earnings Miss Estimates on Higher Costs, Revenues Rise Y/Y